ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,018.39
      -0.34%
      US Tech 100
      16,952.00
      -0.19%
      Dow Jones
      37,903.29
      0.23%
      Brent Oil
      83.725
      0.22%
      Bitcoin
      57,134.63
      -1.91%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Theseus Pharmaceuticals Inc (THRX)

      7. Theseus Pharmaceuticals Inc (THRX) News

      THRX

      Theseus Pharmaceuticals (THRX)

      Theseus Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:THRX
      DateTimeSourceHeadlineSymbolCompany
      02/26/20249:00AMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:THRXTheseus Pharmaceuticals Inc
      02/16/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:THRXTheseus Pharmaceuticals Inc
      02/14/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:THRXTheseus Pharmaceuticals Inc
      02/14/20242:26PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:THRXTheseus Pharmaceuticals Inc
      02/14/20242:24PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:THRXTheseus Pharmaceuticals Inc
      02/14/20242:22PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:THRXTheseus Pharmaceuticals Inc
      02/14/202410:44AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:THRXTheseus Pharmaceuticals Inc
      02/14/202410:35AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
      02/14/20248:30AMPR Newswire (US)Theseus Pharmaceuticals Announces Closing of Tender OfferNASDAQ:THRXTheseus Pharmaceuticals Inc
      02/13/202412:36PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
      02/07/20245:21PMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
      02/07/20245:15PMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
      01/30/20248:52AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
      01/30/20248:23AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
      01/30/20248:00AMBusiness WireConcentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus PharmaceuticalsNASDAQ:THRXTheseus Pharmaceuticals Inc
      01/10/20249:47AMEdgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:THRXTheseus Pharmaceuticals Inc
      01/10/20248:51AMEdgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:THRXTheseus Pharmaceuticals Inc
      12/22/20236:52AMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:THRXTheseus Pharmaceuticals Inc
      12/22/20236:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:THRXTheseus Pharmaceuticals Inc
      12/22/20236:30AMPR Newswire (US)Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value RightNASDAQ:THRXTheseus Pharmaceuticals Inc
      12/04/20236:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:THRXTheseus Pharmaceuticals Inc
      11/27/20236:37AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:THRXTheseus Pharmaceuticals Inc
      11/27/20236:30AMPR Newswire (US)Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLCNASDAQ:THRXTheseus Pharmaceuticals Inc
      11/24/20234:23PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:THRXTheseus Pharmaceuticals Inc
      11/17/20234:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:THRXTheseus Pharmaceuticals Inc
      11/15/20237:00AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:THRXTheseus Pharmaceuticals Inc
      11/13/20234:05PMPR Newswire (US)Theseus Pharmaceuticals Announces Process to Explore Strategic AlternativesNASDAQ:THRXTheseus Pharmaceuticals Inc
      11/07/20234:05PMPR Newswire (US)Theseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:THRXTheseus Pharmaceuticals Inc
      11/07/20234:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:THRXTheseus Pharmaceuticals Inc
      10/31/20234:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:THRXTheseus Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:THRX